XML 47 R34.htm IDEA: XBRL DOCUMENT v3.22.4
Income Taxes (Tables)
 12 Months Ended
Dec. 31, 2022
Income Tax Disclosure [Abstract]  
Schedule of Income before Income Tax, Domestic and Foreign
For financial reporting purposes, income before taxes includes the following components (in thousands):
Years ended December 31,
202220212020
Domestic$(4,979)$(5,956)$(9,476)
Foreign50,067 31,868 27,785 
$45,088 $25,912 $18,309 
Schedule of Components of Income Tax Expense (Benefit)
The expense (benefit) for income taxes is comprised of (in thousands):
Years ended December 31,
202220212020
Current:
Federal$21 $245 $106 
State and local97 38 (18)
Foreign10,457 8,442 6,268 
10,575 8,725 6,356 
Deferred:
Federal(2,808)(2,992)1,718 
State and local109 (588)(422)
Foreign659 324 (143)
(2,040)(3,256)1,153 
Total income tax expense $8,535 $5,469 $7,509 
Schedule of Effective Income Tax Rate Reconciliation
A reconciliation of income tax expense (benefit) at the U.S. federal statutory income tax rate to the actual income tax provision is as follows (in thousands):
Years ended December 31,
202220212020
Tax at statutory rate$9,468 $5,441 $3,845 
State income taxes, net of U.S. federal tax benefit164 (391)(176)
U.S. GILTI tax, net of foreign tax credits8 77 — 
Effect of foreign operations1,246 2,096 729 
Change in valuation allowance(1,629)(1,204)2,448 
Change in unrecognized tax benefits, net(1,000)107 (32)
Impairment of goodwill— 237 507 
Specialty tax credits(639)(333)(249)
Statutory rate changes3 (282)(119)
Effect of foreign exchange667 (35)(346)
Loss of benefit of U.S. net operating loss— — 1,064 
Excess tax benefits related to share based compensation— — (168)
Other247 (244)6 
Total income tax expense $8,535 $5,469 $7,509 
Schedule of Deferred Tax Assets and Liabilities Significant components of the Company’s deferred tax assets and liabilities are as follows (in thousands):
December 31,
20222021
Deferred tax assets:
Pension and other postretirement costs$1,775 $3,580 
Inventories4,057 2,659 
Net operating/capital loss and interest carryforwards9,060 13,562 
Tax credit carryforwards2,372 3,026 
Deferred compensation2,921 3,267 
Research and development costs2,940 832 
Other accruals and reserves2,228 3,593 
Total gross deferred tax assets25,353 30,519 
Less: valuation allowance(10,726)(16,486)
14,627 14,033 
Deferred tax liabilities:
Tax over book depreciation(1,453)(780)
Investment in subsidiary(2,137)(1,958)
Intangible assets, including tax deductible goodwill(10,675)(11,106)
Total gross deferred tax liabilities(14,265)(13,844)
Net deferred tax assets$362 $189 
Summary of Valuation Allowance
Significant valuation allowances are as follows (in thousands):
December 31,
Jurisdiction20222021
U.S. federal$2,647 $4,233 
U.S. state (net of U.S. federal tax benefit)6,026 9,648 
Israel - capital losses1,287 1,537 
Summary of Operating Loss Carryforwards
The following table summarizes significant net operating losses, capital losses and credit carryforwards as of December 31, 2022 (in thousands):
December 31,
Jurisdiction2022Expiring
U.S. federal net operating losses$4,332 No expiration
U.S. federal interest expense carryover6,112 No expiration
U.S. foreign tax credit1,441 2028-2032
U.S. state net operating losses115,028 2023-2042
Israel capital losses5,594 No expiration
Summary of Income Tax Contingencies
The following table summarizes changes in the Company's gross liabilities, excluding interest and penalties, associated with unrecognized tax benefits (in thousands):
December 31,
202220212020
Balance at beginning of year$1,282 $1,244 $1,355 
Addition based on tax positions related to current year176 52 51 
Addition based on tax positions related to prior years216 — — 
Reduction based on tax positions related to prior years— — (57)
Currency translation adjustments(6)41 92 
Reduction for settled tax examinations(1,229)— (73)
Reduction for payments made— — (22)
Reduction for lapses of statute of limitations— (55)(102)
Balance at end of year$439 $1,282 $1,244